| 1 | Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trial. (Khan A, Barber DL, McKillop WM, Rupar CA, Auray-Blais C, Fraser G, Fowler DH, Berger A, Foley R, Keating A, West ML, Medin JA) Clin Transl Med 2025 Jan;15(1):e70073 |
| 2 | Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. (Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM) Sci Rep 2024 Nov 27;14(1):29488 1 Citation |
| 2 | A Case of Fabry Disease With Lacrimal Gland Involvement. (Bruce CN, Mancera N, Grover A, Esmaili N) Ophthalmic Plast Reconstr Surg 2023 Mar-Apr 01;39(2):e52-e55 |
| 1 | Lentivirus-mediated gene therapy for Fabry disease. (Khan A, Barber DL, Huang J, Rupar CA, Rip JW, Auray-Blais C, Boutin M, O'Hoski P, Gargulak K, McKillop WM, Fraser G, Wasim S, LeMoine K, Jelinski S, Chaudhry A, Prokopishyn N, Morel CF, Couban S, Duggan PR, Fowler DH, Keating A, West ML, Foley R, Medin JA) Nat Commun 2021 Feb 25;12(1):1178 114 Citations |
| 1 | Relative distribution of Gb3 isoforms/analogs in NOD/SCID/Fabry mice tissues determined by tandem mass spectrometry. (Provençal P, Boutin M, Dworski S, Au B, Medin JA, Auray-Blais C) Bioanalysis 2016 Sep;8(17):1793-807 16 Citations |
| 1 | Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa. (Schiffmann R, Ries M, Blankenship D, Nicholls K, Mehta A, Clarke JT, Steiner RD, Beck M, Barshop BA, Rhead W, West M, Martin R, Amato D, Nair N, Huertas P) Genet Med 2013 Dec;15(12):983-9 23 Citations |
| 1 | Lentivector transduction improves outcomes over transplantation of human HSCs alone in NOD/SCID/Fabry mice. (Pacienza N, Yoshimitsu M, Mizue N, Au BC, Wang JC, Fan X, Takenaka T, Medin JA) Mol Ther 2012 Jul;20(7):1454-61 25 Citations |
| 1 | Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease. (Lee CJ, Fan X, Guo X, Medin JA) J Cardiol 2011 Jan;57(1):115-22 37 Citations |
| 1 | Alpha-galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice. (Higuchi K, Yoshimitsu M, Fan X, Guo X, Rasaiah VI, Yen J, Tei C, Takenaka T, Medin JA) Mol Med 2010;16(5-6):216-21 14 Citations |
| 1 | Sequencing and characterization of the porcine α-galactosidase A gene: towards the generation of a porcine model for Fabry disease. (Yoshimitsu M, Higuchi K, Fan X, Takao S, Medin JA, Tei C, Takenaka T) Mol Biol Rep 2011 Jun;38(5):3145-52 5 Citations |
| 1 | Immunologic response of the laryngeal mucosa to extraesophageal reflux. (Birchall MA, Bailey M, Gutowska-Owsiak D, Johnston N, Inman CF, Stokes CR, Postma G, Pazmany L, Koufman JA, Phillips A, Rees LE) Ann Otol Rhinol Laryngol 2008 Dec;117(12):891-5 14 Citations |
| 1 | Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus. (Lund N, Branch DR, Sakac D, Lingwood CA, Siatskas C, Robinson CJ, Brady RO, Medin JA) AIDS 2005 Sep 23;19(14):1543-6 32 Citations |
